Skip to main content

Table 2 Specialty of physicians who order molecular testing

From: Analysis of factors influencing molecular testing at diagnostic of colorectal cancer

  KRAS (n = 445) BRAF (n = 133) MSI (n = 138)
Pathologists 174 (39.1%) 38 (28.6%) 34 (24.6%)
Surgeons 105 (23.6%) 22 (16.5%) 21 (15.2%)
Oncologists 84 (18.9%) 37 (27.8%) 43 (31.2%)
Gastroenterologists 9 (2.0%) 1 (0.7%) 1 (0.7%)
Others 4 (0.9%) 7 (5.3%) 5 (3.6%)
Non communicated/unknown 69 (15.5%) 28 (21.1%) 34 (24.6%)